Evidence map›Paper›PMID 28813171›Full record

ArticleJournal of dental research2017

Anti-EDAR Agonist Antibody Therapy Resolves Palate Defects in Pax9

S Jia, J Zhou, Y Wee, M L Mikkola, P Schneider, R N D'Souza

Open access · greenAbstract read
In one paragraph

Article in Journal of dental research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Spatial and Temporal Expression of Ectodysplasin-A Signaling Pathway Members During Mandibular Condylar Development in Postnatal Mice.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The Era of the Genome and Dental Medicine.Journal of dental research · 2019
    Review
  11. Review
  12. Frontiers in physiology · 2017
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

S Jia1 School of Dentistry, School of Medicine, University of Utah, Salt Lake City, UT, USA.
J Zhou1 School of Dentistry, School of Medicine, University of Utah, Salt Lake City, UT, USA.
Y Wee1 School of Dentistry, School of Medicine, University of Utah, Salt Lake City, UT, USA.
M L Mikkola2 Developmental Biology Program, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
P Schneider3 Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.
R N D'Souza1 School of Dentistry, School of Medicine, University of Utah, Salt Lake City, UT, USA.
University of Utah · USUniversity of Helsinki · FIUniversity of Lausanne · CH

Funding

New Molecules and Cures for Tooth AgenesisR01DE027255 · NIDCR · UNIVERSITY OF UTAH · PI JIA, SHIHAI · 2017 to 2020
$2.0M
Signaling Mechanisms in Early Tooth DevelopmentR01DE019471 · NIDCR · UNIVERSITY OF UTAH · PI D'SOUZA, RENA N. · 2009 to 2012
$1.8M
Advancing Molecular Diagnoses and Protein Replacement Therapies in Tooth AgenesisR56DE019471 · NIDCR · UNIVERSITY OF UTAH · PI D'SOUZA, RENA N. · 2016 to 2016
$340k
NIDCR NIH HHS R01 DE019471NIDCR NIH HHS R01 DE027255NIDCR NIH HHS R56 DE019471
6 · The paper itself

Abstract

To date, surgical interventions are the only means by which craniofacial anomalies can be corrected so that function, esthetics, and the sense of well-being are restored in affected individuals. Unfortunately, for patients with cleft palate-one of the most common of congenital birth defects-treatment following surgery is prolonged over a lifetime and often involves multidisciplinary regimens. Hence, there is a need to understand the molecular pathways that control palatogenesis and to translate such information for the development of noninvasive therapies that can either prevent or correct cleft palates in humans. Here, we use the well-characterized model of the Pax9

Indexed as

AnimalsAntibodies, MonoclonalCleft PalateEdar ReceptorGene Expression Regulation, DevelopmentalIn Situ HybridizationMiceMice, Inbred StrainsMorphogenesisPAX9 Transcription FactorPhenotypeReal-Time Polymerase Chain ReactionSignal TransductionAntibodies, MonoclonalEdar protein, mouseEdar ReceptorPAX9 Transcription Factorcleft palatecraniofacial biology/geneticsdevelopmental biologygene expressionmorphogenesistherapeutic treatment

Identifiers

PMID28813171
PMCPMC5613884
OpenAlexW2746407814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.